Indications and uses
fast relief from urinary pain,burning,urgency and frequency associated with urinary tract infections.
fast relief from urinary pain,burning,urgency and frequency associated with urinary tract infections.
■ Adults and children 12 and over: take 2 tablets 3 times daily with a full glass of water, with or after meals as needed ■ Children under 12: consult a doctor ■ Do not use for more than 2 days (12 tablets) without consulting a doctor
Phenazopyridine Hydrochloride 95 mg
Urinary Analgesic
fast relief from urinary pain,burning,urgency and frequency associated with urinary tract infections.
Do not exceed recommended dosage
■ kidney disease
■ allergies to foods, preservatives or dyes
■ had a hypersensitive reaction to Phenazopyridine
■ When using this product stomach upset may occur, taking this product with or after meals may reduce stomach upset
■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
■ your symptoms last for more than 2 days
■ you suspect you are having an adverse reaction to the medication
ask a health professional before use.
in case of an overdose,get medical help or contact a Poison Control Center right away.
■ Adults and children 12 and over: take 2 tablets 3 times daily with a full glass of water, with or after meals as needed
■
Children under 12: consult a doctor
■
Do not use for more than 2 days (12 tablets) without consulting a doctor
lactose, magnesium silicate, magnesium stearate, microcrystalline
cellulose, pharmaceutical glaze, and sodium starch glycolate. May also contain: corn starch,
croscarmellose sodium, polyvinylpyrrolidone, pregelatinized starch and silicon dioxide.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-4417-3 | 2024-06-10 | C162847 | 48780-1 | ba0f9c33-43ce-a910-e053-dadaa90a0b85 | DRUG FACTS |
| 68071-4417-3 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-43ce-a910-e053-dadaa90a0b85 | DRUG FACTS |
| 68071-4417-3 | 2021-02-16 | C162847 | 48780-1 | ba0f9c33-43ce-a910-e053-dadaa90a0b85 | DRUG FACTS |
| 68071-4417-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-43ce-a910-e053-dadaa90a0b85 | DRUG FACTS |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68071-4417 | 68071-4417-3 |
| 10956-551 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| SHELLAC | 46N107B71O | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| SODIUM STARCH GLYCOLATE TYPE A CORN | AG9B65PV6B | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| MAGNESIUM SILICATE | 9B9691B2N9 | IACT |
| PHENAZOPYRIDINE HYDROCHLORIDE | 0EWG668W17 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Preferred Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Reese Pharmaceutical Co | 668f59c9-e543-49fc-96f5-a8077f760529 | 2024-12-18 | Warnings | 10956-551 |
| 1a8c2358-eada-a2b9-e063-6294a90a3cb4 | 6b693369-4ba4-277f-e053-2a91aa0a1b3e | 2024-06-10 | Warnings | 6b693369-4ba4-277f-e053-2a91aa0a1b3e |
Adverse event summaries are temporarily unavailable. Other product information remains available.